Gelernt MD, Herbert V (1982). "Mutagenicity of diisopropylamine dichloroacetate, the "active constituent" of vitamin B15 (pangamic acid)". Nutr Cancer. 3 (3): 129–33. doi:10.1080/01635588109513714. PMID6752894.
Herbert V, Gardner A, Colman N (June 1980). "Mutagenicity of dichloroacetate, an ingredient of some formulations of pangamic acid (trade-named "vitamin B15")". Am. J. Clin. Nutr. 33 (6): 1179–82. doi:10.1093/ajcn/33.6.1179. PMID6992558.
espacenet.com
worldwide.espacenet.com
US 2464240, "Therapeutic material and method of obtaining the same"
US 2710876, "N-substituted glycine esters of gluconic acid"
KREBS ET Sr; KREBS ET Jr; BEARD HH; MALIN R; HARRIS AT; BARTLETT CL (1951). "Pangamic acid sodium: A newly isolated crystalline water-soluble factor; a preliminary report". International Record of Medicine and General Practice Clinics. 164 (1): 18–23. PMID14840945.
Gelernt MD, Herbert V (1982). "Mutagenicity of diisopropylamine dichloroacetate, the "active constituent" of vitamin B15 (pangamic acid)". Nutr Cancer. 3 (3): 129–33. doi:10.1080/01635588109513714. PMID6752894.
Herbert V, Gardner A, Colman N (June 1980). "Mutagenicity of dichloroacetate, an ingredient of some formulations of pangamic acid (trade-named "vitamin B15")". Am. J. Clin. Nutr. 33 (6): 1179–82. doi:10.1093/ajcn/33.6.1179. PMID6992558.